Abstract
There is growing consensus that myocardial perfusion deficits play a pivotal role in the transition from compensated to overt decompensated hypertrophy. The purpose of this study was to systematically study myocardial perfusion deficits in the highly relevant model of pressure overload induced hypertrophy and heart failure by transverse aortic constriction (TAC), which was not done thus far. Regional left ventricular (LV) myocardial perfusion (mL/min/g) was assessed in healthy mice (n = 6) and mice with TAC (n = 14). A dual-bolus first-pass perfusion MRI technique was employed to longitudinally quantify myocardial perfusion values between 1 and 10 weeks after surgery. LV function and morphology were quantified from cinematographic MRI. Myocardial rest perfusion values in both groups did not change significantly over time, in line with the essentially constant global LV function and mass. Myocardial perfusion was significantly decreased in TAC mice (4.2 ± 0.9 mL/min/g) in comparison to controls (7.6 ± 1.8 mL/min/g) (P = 0.001). No regional differences in perfusion were observed within the LV wall. Importantly, increased LV volumes and mass, and decreased ejection fraction correlated with decreased myocardial perfusion (P < 0.001, in all cases). Total LV blood flow was decreased in TAC mice (0.5 ± 0.1 mL/min, P < 0.001) in comparison to control mice (0.7 ± 0.2 mL/min). Myocardial perfusion in TAC mice was significantly reduced as compared to healthy controls. Perfusion was proportional to LV volume and mass, and related to decreased LV ejection fraction. Furthermore, this study demonstrates the potential of quantitative first-pass contrast-enhanced MRI for the study of perfusion deficits in the diseased mouse heart.
Similar content being viewed by others
References
Denolin H, Kuhn H, Krayenbuehl HP et al (1983) The definition of heart failure. Eur Heart J 4(7):445–448
Juenger J, Schellberg D, Kraemer S et al (2002) Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 87(3):235–241
de Couto G, Ouzounian M, Liu PP (2010) Early detection of myocardial dysfunction and heart failure. Nat Rev Cardiol 7(6):334–344
Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 121(7):e46–e215
McMurray JJ, Stewart S (2000) Epidemiology, aetiology, and prognosis of heart failure. Heart 83(5):596–602
Cokkinos DV, Pantos C (2011) Myocardial remodeling, an overview. Heart Fail Rev 16:1–4
Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45–79
Neubauer S (2007) The failing heart—an engine out of fuel. N Engl J Med 356(11):1140–1151
Shiojima I, Sato K, Izumiya Y et al (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115(8):2108–2118
Vatner SF, Hittinger L (1993) Coronary vascular mechanisms involved in decompensation from hypertrophy to heart failure. J Am Coll Cardiol 22(4 Suppl A):34A–40A
Mathiassen ON, Buus NH, Sihm I et al (2007) Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 25(5):1021–1026
Levy BI, Schiffrin EL, Mourad JJ et al (2008) Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation 118(9):968–976
Dai Z, Aoki T, Fukumoto Y et al (2012) Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. J Cardiol 60(5):416–421
Hoenig MR, Bianchi C, Rosenzweig A et al (2008) The cardiac microvasculature in hypertension, cardiac hypertrophy and diastolic heart failure. Curr Vasc Pharmacol 6(4):292–300
Cecchi F, Olivotto I, Gistri R et al (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349(11):1027–1035
Nakajima H, Onishi K, Kurita T et al (2010) Hypertension impairs myocardial blood perfusion reserve in subjects without regional myocardial ischemia. Hypertens Res 33(11):1144–1149
Hartley CJ, Reddy AK, Madala S et al (2008) Doppler estimation of reduced coronary flow reserve in mice with pressure overload cardiac hypertrophy. Ultrasound Med Biol 34(6):892–901
Givvimani S, Munjal C, Gargoum R et al (2011) Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure. J Appl Physiol 110(4):1093–1100
Oudit GY, Kassiri Z, Zhou J et al (2008) Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. Cardiovasc Res 78(3):505–514
van Deel ED, de Boer M, Kuster DW et al (2011) Exercise training does not improve cardiac function in compensated or decompensated left ventricular hypertrophy induced by aortic stenosis. J Mol Cell Cardiol 50(6):1017–1025
Streif JUG, Nahrendorf M, Hiller K-H et al (2005) In vivo assessment of absolute perfusion and intracapillary blood volume in the murine myocardium by spin labeling magnetic resonance imaging. Magn Reson Med 53(3):584–592
Jacquier A, Kober F, Bun S et al (2011) Quantification of myocardial blood flow and flow reserve in rats using arterial spin labeling MRI: comparison with a fluorescent microsphere technique. NMR Biomed 24(9):1047–1053
Decking UKM, Pai VM, Bennett E et al (2004) High-resolution imaging reveals a limit in spatial resolution of blood flow measurements by microspheres. Am J Physiol Heart Circ Physiol 287(3):H1132–H1140
Coolen BF, Moonen RPM, Paulis LEM et al (2010) Mouse myocardial first-pass perfusion MR imaging. Magn Reson Med 64(6):1658–1663
Makowski M, Jansen C, Webb I et al (2010) First-pass contrast-enhanced myocardial perfusion MRI in mice on a 3-T clinical MR scanner. Magn Reson Med 64(6):1592–1598
van Nierop BJ, Coolen BF, Dijk WJR et al (2012) Quantitative first-pass perfusion MRI of the mouse myocardium. Magn Reson Med 69(6):1735–1744
Rockman HA, Ross RS, Harris AN et al (1991) Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88(18):8277–8281
van Nierop BJ, van Assen H, van Deel ED et al (2013) Phenotyping of left and right ventricular function in mouse models of compensated hypertrophy and heart failure with cardiac MRI. PLoS One 8(2):e55424
Köstler H, Ritter C, Lipp M et al (2004) Prebolus quantitative MR heart perfusion imaging. Magn Reson Med 52(2):296–299
Jerosch-Herold M, Wilke N, Stillman AE (1998) Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 25(1):73–84
Valentinuzzi ME, Geddes LA, Baker LE (1969) A simple mathematical derivation of the Stewart–Hamilton formula for the determination of cardiac output. Med Biol Eng 7(3):277–282
Kawecka-Jaszcz K, Czarnecka D, Olszanecka A et al (2008) Myocardial perfusion in hypertensive patients with normal coronary angiograms. J Hypertens 26(8):1686–1694
Izumiya Y, Shiojima I, Sato K et al (2006) Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 47(5):887–893
Duncker DJ, de Beer VJ, Merkus D (2008) Alterations in vasomotor control of coronary resistance vessels in remodelled myocardium of swine with a recent myocardial infarction. Med Biol Eng Comput 46(5):485–497
Bache RJ (1988) Effects of hypertrophy on the coronary circulation. Prog Cardiovasc Dis 30(6):403–440
Kober F, Iltis I, Cozzone PJ et al (2004) Cine-MRI assessment of cardiac function in mice anesthetized with ketamine/xylazine and isoflurane. Magn Reson Mater Phys Biol Med 17(3–6):157–161
You J, Wu J, Ge J et al (2012) Comparison between adenosine and isoflurane for assessing the coronary flow reserve in mouse models of left ventricular pressure and volume overload. Am J Physiol Heart Circ Physiol 303(10):H1199–H1207
Braunwald E (1971) Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 27(4):416–432
Soler R, Rodríguez E, Monserrat L et al (2006) Magnetic resonance imaging of delayed enhancement in hypertrophic cardiomyopathy: relationship with left ventricular perfusion and contractile function. J Comput Assist Tomogr 30(3):412–420
Gould KL, Carabello BA (2003) Why angina in aortic stenosis with normal coronary arteriograms? Circulation 107(25):3121–3123
Gao X-M, Kiriazis H, Moore X-L et al (2005) Regression of pressure overload-induced left ventricular hypertrophy in mice. Am J Physiol Heart Circ Physiol 288(6):H2702–H2707
Kober F, Iltis I, Cozzone PJ et al (2005) Myocardial blood flow mapping in mice using high-resolution spin labeling magnetic resonance imaging: influence of ketamine/xylazine and isoflurane anesthesia. Magn Reson Med 53(3):601–606
Acknowledgments
We thank L. Niesen, D. Veraart and J. Habets for biotechnical assistance and T. van Osch (Leiden University Medical Center) for discussions. This research was performed within the framework of the Center for Translational Molecular Medicine, project TRIUMPH (Grant 01C-103), and supported by the Netherlands Heart Foundation.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
van Nierop, B.J., Coolen, B.F., Bax, N.A. et al. Myocardial perfusion MRI shows impaired perfusion of the mouse hypertrophic left ventricle. Int J Cardiovasc Imaging 30, 619–628 (2014). https://doi.org/10.1007/s10554-014-0369-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-014-0369-0